UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 3, 2005
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
-----------------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
----------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
Ultralife Batteries, Inc. (the "Company") announced that it will report its
fourth quarter 2004 results for the period ended December 31, 2004 before the
market opens on Thursday, February 10, 2005. The Company's press release is
attached as Exhibit 99.1 to this Form 8-K, and the information set forth therein
is furnished under item 7.01.
Item 9.01. Financial Statements, Pro Forma Financials and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated February 3, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: February 3, 2005. By: /s/ Robert W. Fishback
----------------------
Vice President of Finance &
Chief Financial Officer
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated February 3, 2005.
Exhibit 99.1
Ultralife Batteries, Inc. to Report Fourth Quarter Results on February 10, 2005
- Investor Conference Call to be Webcast at Ultralife Batteries' Web Site -
NEWARK, N.Y.--(BUSINESS WIRE)--Feb. 3, 2005--Ultralife Batteries, Inc.
(NASDAQ: ULBI) will report its fourth quarter 2004 results for the period ended
December 31, 2004 before the market opens on Thursday, February 10, 2005.
Ultralife management will host an investor conference call at 10:00AM ET also on
February 10, 2005. Investors are invited to access a live webcast of the
conference call in the Investor Info - Event Calendar section of the company's
website: http://www.ultralifebatteries.com/invest.asp. A replay of the webcast
will be available shortly after the call at the same location and will be
archived for 90 days.
About Ultralife Batteries, Inc.
Ultralife is a global provider of power solutions for diverse applications.
The company develops, manufactures and markets a wide range of non-rechargeable
and rechargeable batteries, charging systems and accessories for use in
military, industrial and consumer portable electronic products. Through its
range of standard products and engineered solutions, Ultralife is able to
provide the next generation of power systems. Industrial, retail and government
customers include General Dynamics, Philips Medical Systems, Energizer, Kidde
Safety, Lowe's, Radio Shack and the national defense agencies of the United
States and United Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research facilities
are in Newark, New York, near Rochester. Ultralife (UK) Ltd., a second
manufacturing facility, is located in Abingdon, U.K. Both facilities are
ISO-9001 certified.
Detailed information on Ultralife is available at the Company's web site,
www.ultralifebatteries.com.
CONTACT: Ultralife Batteries, Inc.
Robert W. Fishback, 315-332-7100
bfishback@ulbi.com
or
Investor Relations:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com
or
Media:
Lippert/Heilshorn & Associates, Inc.
Chenoa Taitt, 212-201-6635
ctaitt@lhai.com